ALS-L1023

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameALS-L1023
Drug Alias NameMcEyeMelissa leaf ethyl acetate dried extractALS-L1023
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionVascular endothelial growth factor A inhibitorsMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinaseVascular endothelial growth factor A
Therapy Area/IndicationsObesity, AbdominalMetabolic SyndromeRosacea +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazilSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAngiolab Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngiolab IncUniversidade Federal Do Rio De Janeiro
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsRosaceaMacular DegenerationOtitis Media with Effusion +[5] 
Inactive IndicationsObesity, AbdominalMetabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A